Alba VE, Tamayo CR

Language: Spanish
References: 20
Page: 393-397
PDF size: 511.77 Kb.

ABSTRACT

Objective: Clinically and epidemiologically characterize the new cases of pulmonary TB with HIV positive in the Hospital Sanatorium of Luanda in the years 2014 and 2015.
Method: A descriptive cross-sectional investigation and a quantitative approach with a probabilistic sample of 148 cases from the universe of patients diagnosed with a new case of pulmonary TB and HIV positive who took antibacillary treatment, the data were collected f rom the medical records.
Results: The population studied had a mean age of 36.7 (SD. ± 8.2) years, the male sex predominated with 51.3% of the cases, stage III for HIV / AIDS was the majority, the most cough, fever and weight loss were frequent, at the diagnosis of TB the patients had a median of 200.0 cells / mm3 of CD4, more than 85% were unaware of their HIV status and a predominance of negative smear microscopy was observed. 92 cases; the antibacillary treatment was successful in 66.2% of the cases, 23.0% of the cases abandoned it and in 66.2% it was combined with antiretrovirals.
Conclusions: In the diagnosis of TB, most of the patients were unaware of their serological status and had an advanced stage of HIV/AIDS with deterioration of their CD4 levels, which facilitated the clinical presentation of TB as an opportunistic disease with a predominance of negative sputum smear microscopy, patients presented good response to antibacillary and antiretroviral treatment.

REFERENCES

1. World Health Organization (WHO) Global Tuberculosis Report 2016. WHO/HTM/TB/2016.13. Geneva: Switzerland: WHO; 2016.

2. World Health Organization. Treatment of tuberculosis: guidelines for national programmes: 3rd ed. Geneva: Switzerland: WHO; 2003.

3. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global AIDS Response Progress Reporting 2015. UNAIDS/JC2702E. Geneva: Switzerland: UNAIDS; 2015

4. World Health Organization (WHO) Global Tuberculosis Report 2015. WHO/HTM/TB/2015.22. Geneva: Switzerland: WHO; 2015

5. Valadas E, Gomes A, Sutre A, Brilha S, Wete A, Hänscheid T, et al. Tuberculosis with malaria or HIV co-infection in a large hospital in Luanda, Angola, J Infect Dev Ctries 2013, 7(3):269-272.

6. Programa Nacional de Controlo da Tuberculose e Lepra. Angola (PNCTRA). Guia para o tratamento da Tuberculose, 3ra ed. Luanda: Ministério da Saúde; 2013.

7. Instituto Nacional de Luta Contra a Sida (INLS), Ministério da Saúde Angola. Normas sobre Tratamento Anti-Retroviral em adultos e adolescentes, 3 ed., Luanda:Ministerio da Saúde, 2011

8. Chu R., Mills EJ., Beyene J., Pullenayegum E., Bakanda C., Nachega JB.,et al. Impact of tuberculosis on mortality among HIV-infected patients receiving antiretroviral therapy in Uganda: a prospective cohort analysis, AIDS Res Ther. [Internet]. 2013 [citado 22 Oct 2015], 10:19. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC3716897/pdf/1742-6405-10-19.pdf

9. Chukwunweolu D., Nakalema S., Alobu I., Ukwaja K. Profile, Outcomes, and Determinants of Unsuccessful Tuberculosis Treatment Outcomes among HIV-Infected Tuberculosis Patients in a Nigerian State, Tuberc Res Treat. [Internet]. 2014 [citado 22 Oct 2015], 2014:202983. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC4248359/

10. Sharma SK., Soneja M., Prasad KT., Ranjan S. Clinical profile & predictors of poor outcome of adult HIV-tuberculosis patients in a tertiary care centre in north India, Indian J Med Res. 2014, 139(1):154–160.

11. Kamath K, Sharma V, Pattanshetty S, Hegde MB, Chandrasekaran V. HIV-TB coinfection: Clinico-epidemiological determinants at an antiretroviral therapy center in Southern India. Lung India. 2013 Oct-Dec; 30(4): 302–306.

12. Mor Z, Lidji M, Chemtob D, Cedar N, Grotto I. HIV prevalence in the Israeli tuberculosis cohort, 1999–2011, BMC Public Health. [Internet]. 2014 [citado 22 Oct 2015], 14(1): 1090. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221682/

13. Iliyasu Z., Babashani M. Prevalence and Predictors of Tuberculosis Coinfection among HIV-Seropositive Patients Attending the Aminu Kańo Teaching Hospital, Northern Nigeria, J Epidemiol 2009;19(2):81-87 doi:10.2188/jea.JE20080026

14. Médecins Sans Frontičres and Partners In Health. Tuberculosis: Practical guide for clinicians, nurses, laboratory technicians and medical auxiliaries. [Internet]. Saint Denis. France: Médecins Sans Frontičres; 2014. [citado 24 Jun 2017]. Disponible en: http://refbooks.msf.org/msf_docs/en/tuberculosis/tuberculosis_en.pdf

15. Thuy TT, Shah NS, Anh MH, Nghia DT, Thom D, et al. (2007) HIV-associated TB in An Giang Province, Vietnam, 2001–2004: epidemiology and TB treatment outcomes. PLoS ONE [Internet]. 2007 [citado 24 Jun 2017];2(6, article e507) Disponible en: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0000507

16. Kouassi B, N’Gom A, Horo K, Godé C, Ahui B, et al. Corrélations des manifestations de la tuberculose pulmonaire avec le degré d’immunodépression au VIH. Revue des Maladies Respiratoires 2016;30(7):549-554

17. Azis L, Jones-López EC, Ellner JJ. HIV-associated tuberculosis En: Volberding P, Greene W, Lange JMA, Gallant JE, Sewankambo N. Sande’s HIV/AIDS Medicine: Medical Management of AIDS 2013: 2nd Ed. Elsevier Inc., 2012. p. 225-247

18. Stockdale AJ., Nkuranga J., Török ME., Faragher B., Lalloo DG. Initiation of Antiretroviral Therapy in HIV-Infected Tuberculosis Patients in Rural Kenya: An Observational Study, Trop Med Int Health. Jul 2013; 18(7): 907–914.

19. Mendoza A., Iglesias D. Tuberculosis en pacientes con VIH/Sida. Acta Med Per 2008, 25(4):247-254.

20. Yokoa JLM, Tumboa JM, Millsa AB, Kabongoa CD. Characteristics of pulmonary tuberculosis patients in Moses Kotane region North West Province, South Africa. South African Family Practice 2017; 59(2):78–81